PODCAST · technology
The Pulse Podcast
by Brought to you by the Harvard Biotech Club
The Pulse Podcast takes a deep dive into biotech stories, features key biotech figures, and inspires the next generation of biotech leaders. The Pulse is presented by the Harvard Biotech Club. hbcpulse.substack.com
Episodes
-
Carl Novina: From Academic Discovery to Company Creation
Dr. Carl Novina is a physician-scientist, biotech founder, and Science Partner at Flagship Pioneering. Before joining Flagship, he spent nearly two decades as a principal investigator at Harvard Medical School, Dana-Farber Cancer Institute, and Broad Institute, where he studied RNA biology…
more -
Tasuku Kitada: Building a Biotech Strand by Strand
Dr. Tasuku Kitada is the co-founder, President, Head of R&D, and a board director at Strand Therapeutics, a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancer, autoimmune disease, and in vivo cell engineering. Tasuku received his B.S. in Biophysics and...
-
Ryan Flynn: The Wonderful World of GlycoRNA
Ryan Flynn is pioneering a brand new field of biology. His seminal report of glycosylated RNA (glycoRNA) in 2021 reimagined the way we think about the cell surface and intercell communication. The discovery of glycoRNA revealed that cells intentionally express RNA on their surfaces and these RNAs...
-
Chuan He: Philosophies on the Wall Between Academia and Industry
Chuan He is a world-renowned epigeneticist, a Wolf Prize laureate, and a recent inductee of the National Academy of Sciences. Chuan’s lab at the University of Chicago has spun out numerous companies including Ellis Bio (DNA methylation detection technologies) and Aferna Bio (plant biology). His...
-
Mark Namchuk: The Art of the Argument Between Science and Business at Every Level
Mark Namchuk is the Executive Director of Therapeutics Translation at Harvard Medical School. Before he joined Harvard, Mark had a 24-year research and development career in the biotech industry, working in a number of areas, including drug discovery, translational science and pharmaceutical...
-
Vicki Sato: Building Modern Biotech Through the Pull and Push
Dr Vicki Sato is a pioneering biotech leader who helped shape the modern biotech industry. She currently serves on the board or in the advisory role for several biotech companies, including Vir Biotechnology, Denali Therapeutics, Allogene Therapeutics, and as a venture partner at ARCH Venture...
-
James Collins: Doing Good Science with an Underdog Spirit
James Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. Jim serves as a director at the MIT Jameel Clinic, a member of the Harvard-MIT Health Sciences & Technology Faculty, a core founding faculty member of the Wyss Institute, and a...
-
Tim Harris: a Journey through 50 years of Biotechnology
Tim Harris is a molecular biologist, biochemist and geneticist. He is also a science and business leader with over 40 years of experience in a range of molecular research areas. Tim is currently an Operating Partner at SV Health Investors. Outside of SV, he holds a seat on the Board of Directors…
more -
Stephanie Oestreich: Leadership across biotech and orchestras
Stephanie Oestreich is Managing Director of the Myeloma Investment Fund (MIF), a venture philanthropy fund focused on therapies and technologies for multiple myeloma. She is the chair of the McCloy Alumni Association. She is also a faculty member at MIT, and an advisor at multiple drug…
more -
Luke Timmerman: Daring to Traverse Biotech and Mountains
Luke Timmerman is a biotech journalist, author, entrepreneur, and philanthropist. As an award-winning journalist, Luke has been covering biotech since 2001. He is the founder and editor of Timmerman Report, a leading biotech industry newsletter. He hosts “The Long Run”, a biotech-focused podcast...
-
Bill Sellers: A Nonlinear Journey in Advancing Cancer Therapeutics Across Academia and Industry
Dr. Bill Sellers is a physician scientist and a leading cancer researcher who has held major roles across academia and industry, including Core member of the Broad Institute and Professor at Dana-Farber Cancer Institute and Harvard Medical School. Bill helped pioneer cancer genomics, including…
more -
Melissa McCracken: A Scientist’s Journey into Biotech VC
Melissa McCracken is a partner at Nextech Invest, a leading oncology-focused venture capital firm. She is a board member for multiple private and public biotech companies. Melissa is a scientist by training from UCLA with her research on engineered immunity for cancer. She also completed her...
-
Soufiane Aboulhouda: A story of startups and serendipity
Soufiane (Souf) is a synthetic biologist by training from Harvard Medical School. During his PhD, he founded Nucleate, a non-profit biotech organization that represents the largest global community of bio-innovators and offers numerous free entrepreneurship programs for academic trainees. In this...
-
John Maraganore: The Importance of Being Unreasonable
Dr. John Maraganore, founding CEO of Alnylam Pharmaceuticals and co-founder of City Therapeutics, discusses his journey from a Greek immigrant household to pioneering RNA interference (RNAi) therapeutics. He highlights Alnylam’s growth from a startup to a major biotech company, leading to the…
more -
George Church: Embracing Outliers in Science and in Life
Dr. George Church, is a genetics professor at Harvard Medical School and the Wyss Institute. George is a pioneer in synthetic biology and personalized genomics. In 2017, Time magazine named him as one of the 100 most influential people in the world. In addition to being a scientist, George is…
more -
Chris Bahl: From Protein Geek to Biotech CEO
Chris Bahl is the Co-founder and CEO of AI Proteins. He also established the Boston Protein Design and Modeling Club (BPDMC), where he serves as Co-organizer. After completing his PhD in biochemistry from Dartmouth, Chris joined David Baker Lab at the University of Washington, where he pioneered...
-
Peter Kolchinsky: Create Your Own Luck by Doing Things Outside of Class
Peter Kolchinsky: Scientist, investor, author, founder of No Patient Left Behind, and co-founder of RA Capital Management. Peter is a virologist by training from Harvard University. After finishing his PhD, he went on to create RA Capital, a leading biotech venture capital firm. In this episode,...
-
Madalyn Won: Making the Jump from Academia into Consulting
Maddie is a parasitologist by training from Harvard University. After her PhD graduation, she joined McKinsey as an associate. In this episode, Maddie shared her journey from the lab to consulting. This is a public episode. If you would like to discuss this with other subscribers or get access to...
-
Emily Gaudiano: From Lab Bench to Biotech Venture Capital
* Emily Gaudiano reflects on her PhD in Arlene Sharpe Lab at Harvard Medical School and shares the pivotal moments that influenced her career. * With experience in recruiting interns for VC, she offers valuable insights and actionable strategies for graduates aspiring to break into biotech VC. *...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The Pulse Podcast takes a deep dive into biotech stories, features key biotech figures, and inspires the next generation of biotech leaders. The Pulse is presented by the Harvard Biotech Club.
hbcpulse.substack.com
HOSTED BY
Brought to you by the Harvard Biotech Club
CATEGORIES
Loading similar podcasts...